SAFETY AND EFFICACY OF TIAGABINE HCL AS ADJUNCTIVE TREATMENT

这是一项开放水平、非比较、附加治疗的扩展研究，研究对象为先前曾参与盐酸替加他滨癫痫研究的患者。然而，在研究过程中，伴随的AEDs可能会逐渐停用，因此一些患者可能会获得盐酸替加宾的单一治疗。这项研究可以在美国任何正在进行或已经进行盐酸替加宾临床研究的地点进行。本研究的目的是确定盐酸替加宾作为癫痫慢性治疗药物的安全性。

This is an open-lavel, noncomparative, add-on therapy, extension study in patient who have previously participated in a tiagabine HCL epilepsy study. However, during the course of the study concomitant AEDs may be gradually withdrawn so that some patients may be expected to achieve tiagabine HCL monotherapy. This study may be conducted at any site that is conducting or has conducted, tiagabin HCL clinical studies in the United States. The objective of this study is to determine the safety of tiagabine HCl as chronic therapy for epilepsy.